|
|
regulation of nlrp3 inflammasome complex assembly
|
GO:1900225 |
4 |
0.701
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.497
|
|
|
|
negative regulation of nlrp3 inflammasome complex assembly
|
GO:1900226 |
2 |
0.423
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.417
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.389
|
|
|
|
positive regulation of viral genome replication
|
GO:0045070 |
2 |
0.261
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.245
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.225
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.215
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.214
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.192
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.187
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.174
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.166
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.165
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.159
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.154
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.151
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.148
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.147
|
|
|
|
interferon beta production
|
GO:0032608 |
16 |
0.144
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.136
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.126
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.125
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.124
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.120
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.119
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.108
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.106
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.098
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.096
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.094
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.090
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.089
|
|
|
|
negative regulation of viral genome replication
|
GO:0045071 |
10 |
0.089
|
|
|
|
rig i signaling pathway
|
GO:0039529 |
4 |
0.087
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.087
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
18 |
0.086
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.086
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.079
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.078
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.078
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
15 |
0.078
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
23 |
0.078
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.077
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.077
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.077
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.075
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.073
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.071
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.071
|
|
|
|
viral genome replication
|
GO:0019079 |
17 |
0.069
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.068
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.068
|
|
|
|
type i interferon production
|
GO:0032606 |
29 |
0.065
|
|
|
|
regulation of viral release from host cell
|
GO:1902186 |
6 |
0.064
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.064
|
|
|
|
cellular response to interferon beta
|
GO:0035458 |
21 |
0.063
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.062
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.062
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.059
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.059
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.058
|
|
|
|
cellular response to interferon alpha
|
GO:0035457 |
4 |
0.058
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.058
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.057
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.056
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.055
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.054
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.054
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.051
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.051
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.051
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.050
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.050
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.050
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.050
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.050
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.050
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.048
|
|
|
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
1 |
0.048
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.047
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.047
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.047
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.047
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.047
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.047
|
|
|
|
negative regulation of interleukin 6 production
|
GO:0032715 |
17 |
0.046
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.046
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.046
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.046
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.045
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.045
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.045
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.044
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.042
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway in response to virus
|
GO:0039528 |
4 |
0.041
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.040
|
|
|
|
negative regulation of viral release from host cell
|
GO:1902187 |
6 |
0.040
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.039
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.038
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.038
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.038
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
13 |
0.038
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.037
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.037
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.037
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.037
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.037
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.037
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.036
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.036
|
|
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
15 |
0.036
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.036
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.036
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.036
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.035
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.035
|
|
|
|
regulation of viral genome replication
|
GO:0045069 |
13 |
0.035
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.035
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.034
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.034
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.034
|
|
|
|
positive regulation of actin nucleation
|
GO:0051127 |
3 |
0.034
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.034
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.033
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.033
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.033
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.033
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.033
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.032
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.032
|
|
|
|
regulation of type i interferon production
|
GO:0032479 |
22 |
0.032
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.032
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.032
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.031
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.031
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.031
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.031
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.031
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.031
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.031
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.031
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.031
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.030
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.029
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.029
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.029
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.029
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.029
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.029
|
|
|
|
nlrp3 inflammasome complex assembly
|
GO:0044546 |
5 |
0.029
|
|
|
|
response to interferon beta
|
GO:0035456 |
22 |
0.029
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.028
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.028
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.028
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.028
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.027
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
30 |
0.027
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.027
|
|
|
|
entry into host
|
GO:0044409 |
15 |
0.027
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.027
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.027
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.027
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.026
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.026
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.026
|
|
|
|
natural killer cell proliferation
|
GO:0001787 |
3 |
0.026
|
|
|
|
interaction with host
|
GO:0051701 |
22 |
0.026
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.026
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.026
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.026
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.025
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.025
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.025
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.025
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.025
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.025
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.025
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.025
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.025
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.025
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.024
|
|
|
|
regulation of rig i signaling pathway
|
GO:0039535 |
2 |
0.024
|
|
|
|
pre mirna processing
|
GO:0031054 |
3 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.024
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.024
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.024
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.024
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.023
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.023
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.023
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.023
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.023
|
|
|
|
citrate metabolic process
|
GO:0006101 |
3 |
0.023
|
|
|
|
regulation of defense response to virus by host
|
GO:0050691 |
8 |
0.023
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.023
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.023
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.022
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.022
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.022
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.022
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.022
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.022
|
|
|
|
response to dsrna
|
GO:0043331 |
30 |
0.022
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.022
|
|
|
|
regulation of natural killer cell mediated cytotoxicity
|
GO:0042269 |
19 |
0.022
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.022
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.021
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.021
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.021
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.021
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.021
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.021
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.021
|
|
|
|
regulation of natural killer cell mediated immunity
|
GO:0002715 |
19 |
0.021
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.021
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.021
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.021
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.021
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.020
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.020
|
|
|
|
positive regulation of viral process
|
GO:0048524 |
5 |
0.020
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.020
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.020
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.020
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.020
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.020
|
|
|
|
entry into other organism involved in symbiotic interaction
|
GO:0051828 |
15 |
0.020
|
|
|
|
regulation of interferon alpha production
|
GO:0032647 |
5 |
0.019
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.019
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.019
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.019
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.019
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.019
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.019
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.019
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.019
|
|
|
|
translation
|
GO:0006412 |
93 |
0.019
|
|
|
|
negative regulation of viral entry into host cell
|
GO:0046597 |
10 |
0.019
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.019
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.019
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.019
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.019
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.019
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.019
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.019
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.018
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.018
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.018
|
|
|
|
positive regulation of type i interferon production
|
GO:0032481 |
14 |
0.018
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.018
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.018
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.018
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.018
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.018
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.018
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.018
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.018
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.018
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.018
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.018
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.018
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.017
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.017
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.017
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.017
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.017
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.017
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.017
|
|
|
|
entry into host cell
|
GO:0030260 |
15 |
0.017
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.017
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.017
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.017
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.017
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.016
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.016
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.016
|
|
|
|
positive regulation of mirna metabolic process
|
GO:2000630 |
1 |
0.016
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.016
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
50 |
0.016
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.016
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.016
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.016
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.016
|
|
|
|
taurine metabolic process
|
GO:0019530 |
4 |
0.016
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.016
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.016
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.016
|
|
|
|
positive regulation of type i interferon mediated signaling pathway
|
GO:0060340 |
4 |
0.016
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.016
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.016
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.015
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.015
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.015
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.015
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.015
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.015
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.015
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.015
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.015
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.015
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.015
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.015
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.015
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.015
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.015
|
|
|
|
movement in host environment
|
GO:0052126 |
15 |
0.015
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.015
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.015
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.015
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.014
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.014
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.014
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
10 |
0.014
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.014
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.014
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.014
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.014
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.014
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.014
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.014
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.014
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.014
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.014
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.014
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.014
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.014
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.014
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.014
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.014
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.014
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.014
|
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.014
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.014
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.014
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.014
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.014
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.014
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.014
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.014
|
|
|
|
hatching
|
GO:0035188 |
4 |
0.014
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.014
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.014
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.014
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.014
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.014
|
|
|
|
regulation of type i interferon mediated signaling pathway
|
GO:0060338 |
7 |
0.014
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.013
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.013
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.013
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.013
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.013
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.013
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.013
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.013
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.013
|
|
|
|
viral entry into host cell
|
GO:0046718 |
15 |
0.013
|
|
|
|
response to type i interferon
|
GO:0034340 |
12 |
0.013
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.013
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.013
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.013
|
|
|
|
regulation of schwann cell proliferation
|
GO:0010624 |
2 |
0.013
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.013
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.013
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.013
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.013
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.013
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.013
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.013
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.013
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.013
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.013
|
|
|
|
positive regulation of natural killer cell mediated immunity
|
GO:0002717 |
16 |
0.013
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.013
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.013
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.013
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.013
|
|
|
|
positive regulation of myelination
|
GO:0031643 |
5 |
0.013
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.013
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.013
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.013
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.013
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.012
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.012
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.012
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.012
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.012
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.012
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.012
|
|
|
|
response to interferon alpha
|
GO:0035455 |
7 |
0.012
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.012
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.012
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.012
|
|
|
|
production of small rna involved in gene silencing by rna
|
GO:0070918 |
6 |
0.012
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.012
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.012
|
|
|
|
positive regulation of cell killing
|
GO:0031343 |
33 |
0.012
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.012
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.012
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.012
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.012
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.012
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.012
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.012
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.012
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.012
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.012
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.012
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.012
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.012
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.012
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.012
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.012
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.012
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.012
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.012
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.012
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway
|
GO:0002753 |
10 |
0.012
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.012
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.012
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
38 |
0.011
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.011
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.011
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.011
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.011
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.011
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.011
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.011
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.011
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.011
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.011
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.011
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.011
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.011
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.011
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.011
|
|
|
|
defense response to protozoan
|
GO:0042832 |
25 |
0.011
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
26 |
0.011
|
|
|
|
regulation of myd88 dependent toll like receptor signaling pathway
|
GO:0034124 |
2 |
0.011
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.011
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.011
|
|
|
|
chemokine production
|
GO:0032602 |
34 |
0.011
|
|
|
|
regulation of interferon beta biosynthetic process
|
GO:0045357 |
4 |
0.011
|
|
|
|
type i interferon signaling pathway
|
GO:0060337 |
10 |
0.011
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.011
|
|
|
|
interferon alpha production
|
GO:0032607 |
7 |
0.011
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.011
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.011
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.011
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.011
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.011
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.011
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.011
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.011
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.011
|
|
|
|
mda 5 signaling pathway
|
GO:0039530 |
1 |
0.011
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.011
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.011
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.011
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.011
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.011
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.011
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.011
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.011
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.011
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.011
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.011
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.011
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.011
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.011
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.010
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.010
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.010
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.010
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.010
|
|
|
|
regulation of viral entry into host cell
|
GO:0046596 |
12 |
0.010
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.010
|
|
|
|
negative regulation of cytoplasmic transport
|
GO:1903650 |
29 |
0.010
|
|
|
|
cellular response to type i interferon
|
GO:0071357 |
10 |
0.010
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.010
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.010
|
|
